We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Pfizer (PFE - Free Report) and its German partner BioNTech (BNTX - Free Report) announced on Monday that their COVID-19 vaccine was more than 90% effective in preventing the disease. Pfizer CEO called the development as “a great day for science and humanity.”
Scientists were hoping for a coronavirus vaccine that is 50% or 60% effective; the 90% rate is significantly above most expectations and puts it almost at par with the measles vaccine. Flu vaccines are about 30% to 60% effective.
The hope that the vaccine might return life to normal sent economically sensitive stocks soaring. Stay at home stocks plunged while stocks that benefit from reopening surged. Safe haven areas like gold and government bonds fell.
The VanEck Vectors Oil Services ETF (OIH - Free Report) , which holds 25 largest US-listed oil services companies, surged more than 18%.
The ETFMG Travel Tech ETF (AWAY - Free Report) holds companies in global travel and tourism industry such as Expedia (EXPE - Free Report) and Uber Technologies (UBER - Free Report) . It was up more than 18%.
Southwest (LUV - Free Report) and Delta (DAL - Free Report) are the top holdings in the US Global Jets ETF (JETS - Free Report) , the only airline ETF available to US investors. It gained more than 16%.
The Invesco KBW Regional Banking ETF (KBWR - Free Report) , which tracks an equal-weighted index of US regional banks, was up more than 16%.
To learn more about these ETFs, please watch the short video above.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Biggest ETF Winners from Coronavirus Vaccine News
Pfizer (PFE - Free Report) and its German partner BioNTech (BNTX - Free Report) announced on Monday that their COVID-19 vaccine was more than 90% effective in preventing the disease. Pfizer CEO called the development as “a great day for science and humanity.”
Scientists were hoping for a coronavirus vaccine that is 50% or 60% effective; the 90% rate is significantly above most expectations and puts it almost at par with the measles vaccine. Flu vaccines are about 30% to 60% effective.
The hope that the vaccine might return life to normal sent economically sensitive stocks soaring. Stay at home stocks plunged while stocks that benefit from reopening surged. Safe haven areas like gold and government bonds fell.
The VanEck Vectors Oil Services ETF (OIH - Free Report) , which holds 25 largest US-listed oil services companies, surged more than 18%.
The ETFMG Travel Tech ETF (AWAY - Free Report) holds companies in global travel and tourism industry such as Expedia (EXPE - Free Report) and Uber Technologies (UBER - Free Report) . It was up more than 18%.
Southwest (LUV - Free Report) and Delta (DAL - Free Report) are the top holdings in the US Global Jets ETF (JETS - Free Report) , the only airline ETF available to US investors. It gained more than 16%.
The Invesco KBW Regional Banking ETF (KBWR - Free Report) , which tracks an equal-weighted index of US regional banks, was up more than 16%.
To learn more about these ETFs, please watch the short video above.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>